- The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathwayJiang Weiliang; Zhao Senlin; Jiang Xiaohua; Zhang Erquan; Hu Guoyong; Hu Bin; Zheng Ping; Xiao Junhua; Lu Zhanjun; Lu Yingying; Ni Jianbo; Chen Congying; Wang Xingpeng; Yang Lijuan; Wan RongCancer Letters, 2016, 371(2): 314-325.
- Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in GlioblastomaSlat Emily A; Sponagel Jasmin; Marpegan Luciano; Simon Tatiana; Kfoury Najla; Kim Albert; Binz Andrea; Herzog Erik D; Rubin Joshua BJournal of Biological Rhythms, 2017, 32(2): 121-129.
- Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinomaLi Wenhua; Liu Ling; Liu Di; Jin Shimao; Yang Yisha; Tang Wei; Gong LeiBiochemical and Biophysical Research Communications, 2016, 472(1): 156-162.
Journal article
Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma
19Reads
